The EU's new paediatric medicines legislation: serving children's needs?
- PMID: 17715445
- PMCID: PMC2084007
- DOI: 10.1136/adc.2006.105692
The EU's new paediatric medicines legislation: serving children's needs?
Abstract
In new legislation for paediatric medicines which came into effect on 26 January 2007, the European Union (EU) has attempted to address several unresolved issues relating to children's needs for medicines in Europe. This article reviews the legislation's main proposals and makes some comparisons with equivalent legislation in the USA. We argue that the legislation suffers from several gaps and uncertainties in relation to the specific proposals and their intended aims. As the establishment of new legislation in this area offered the EU an opportunity to set some clear guidelines and objectives, and had the potential to go beyond the equivalent American rules, we thus see the proposals as something of a disappointment.
Conflict of interest statement
Competing interests: None.
Similar articles
-
Draft EU regulation on paediatric medicines: some improvements but still far from perfect.Prescrire Int. 2006 Feb;15(81):32-3. Prescrire Int. 2006. PMID: 16548115
-
Who are the PDCO?Eur J Pediatr. 2014 Feb;173(2):233-5. doi: 10.1007/s00431-013-2096-2. Epub 2013 Aug 8. Eur J Pediatr. 2014. PMID: 23925423
-
Will children with cancer benefit from the new European Paediatric Medicines Regulation?Eur J Cancer. 2009 Jun;45(9):1535-46. doi: 10.1016/j.ejca.2009.04.008. Epub 2009 May 4. Eur J Cancer. 2009. PMID: 19419857
-
European paediatric research and children's therapeutic needs. A trial review.Acta Paediatr. 2008 Sep;97(9):1232-7. doi: 10.1111/j.1651-2227.2008.00878.x. Epub 2008 May 13. Acta Paediatr. 2008. PMID: 18489618 Review.
-
Progress review of the European Paediatric Regulatory Framework after six years of implementation.Int J Pharm. 2014 Aug 5;469(2):240-3. doi: 10.1016/j.ijpharm.2014.03.019. Epub 2014 Mar 6. Int J Pharm. 2014. PMID: 24613178 Review.
Cited by
-
The new European regulation on pediatric medicines: regulatory perspective.Paediatr Drugs. 2008;10(3):143-6. doi: 10.2165/00148581-200810030-00002. Paediatr Drugs. 2008. PMID: 18454566 No abstract available.
-
The unintended consequences of clinical trials regulations.PLoS Med. 2009 Nov;3(11):e1000131. doi: 10.1371/journal.pmed.1000131. Epub 2009 Nov 17. PLoS Med. 2009. PMID: 19918557 Free PMC article.
-
Immediate rescue designs in pediatric analgesic trials: a systematic review and meta-analysis.Anesthesiology. 2015 Jan;122(1):150-171. doi: 10.1097/ALN.0000000000000445. Anesthesiology. 2015. PMID: 25222831 Free PMC article.
-
How to optimize the evaluation and use of antibiotics in neonates.Pediatr Clin North Am. 2012 Oct;59(5):1117-28. doi: 10.1016/j.pcl.2012.07.004. Epub 2012 Sep 1. Pediatr Clin North Am. 2012. PMID: 23036247 Free PMC article. Review.
-
The Current Status of European and National Financial Sources for Clinical Research and Their Impact on Paediatric Non-commercial Clinical Trials: A Case Study of the Czech Republic.Ther Innov Regul Sci. 2020 Nov;54(6):1461-1472. doi: 10.1007/s43441-020-00173-9. Epub 2020 Jun 5. Ther Innov Regul Sci. 2020. PMID: 32504401 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials